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Abstract: Solar radiation causes damage to human skin, and photoprotection is the main way 
to prevent these harmful effects. The development of sunscreen formulations containing nano-
systems is of great interest in the pharmaceutical and cosmetic industries because of the many 
potential benefits. This study aimed to develop and evaluate an octyl methoxycinnamate (OMC) 
liposomal nanosystem (liposome/OMC) to obtain a sunscreen formulation with improved safety 
and efficacy by retaining OMC for longer on the stratum corneum.
Methods: The liposome/OMC nanostructure obtained was tested for enzymatic hydrolysis with 
lipase from Rhizomucor miehei and biodistribution with liposomes labeled with technetium-99m. 
The liposome/OMC formulation was then incorporated in a gel formulation and tested for ocular 
irritation using the hen’s egg test-chorio-allantoic membrane (HET-CAM) assay, in vitro and in vivo 
sun protection factor, in vitro release profile, skin biometrics, and in vivo tape stripping.
Results: The liposome/OMC nanosystem was not hydrolyzed from R. miehei by lipase. In the 
biodistribution assay, the liposome/OMC formulation labeled with technetium-99m had mainly 
deposited in the skin, while for OMC the main organ was the liver, showing that the liposome 
had higher affinity for the skin than OMC. The liposome/OMC formulation was classified as 
nonirritating in the HET-CAM test, indicating good histocompatibility. The formulation contain-
ing liposome/OMC had a higher in vivo solar photoprotection factor, but did not show increased 
water resistance. Inclusion in liposomes was able to slow down the release of OMC from the 
formulation, with a lower steady-state flux (3.9 ± 0.33 µg/cm2/hour) compared with the conven-
tional formulation (6.3 ± 1.21 µg/cm2/hour). The stripping method showed increased uptake of 
OMC in the stratum corneum, giving an amount of 22.64 ± 7.55 µg/cm2 of OMC, which was 
higher than the amount found for the conventional formulation (14.57 ± 2.30 µg/cm2).
Conclusion: These results indicate that liposomes are superior carriers for OMC, and confer 
greater safety and efficacy to sunscreen formulations.
Keywords: sunscreen, liposome, tape stripping, technetium-99-m, lipase
Introduction
Photoprotection is the main way of preventing damage caused by solar radiation, ie, 
erythema, aging, and skin cancer. Nonmelanoma skin cancer is the most common tumor 
type in Brazil.1 Currently, 2–3 million nonmelanoma skin cancers and 132,000 mela-
noma skin cancers occur globally each year. One in every three cancers diagnosed 
worldwide is a skin cancer, according to Skin Cancer Foundation statistics.2 Antisolar 
preparations contain sunscreens that absorb, reflect, or scatter ultraviolet radiation from 
sunlight. For more photostable formulations, with a high sun protection factor (SPF) 
and providing broad spectrum ultraviolet radiation protection, three or more   sunscreen International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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agents are used. These agents are generally lipophilic 
substances applied on a large area of the body. Therefore, 
systemic absorption is a factor to be considered.3–7
The anti-ultraviolet B organic filter, octyl p-methoxycin-
namate (OMC), first developed in the 1950s, has been one of 
the most widely used sunscreens, and its use in pharmaceuti-
cal and cosmetic formulations is allowed by, among other 
entities, the US Food and Drug Administration, the European 
Cosmetics, Toiletry, and Perfumery Association (COLIPA) 
and the Brazilian Agência Nacional de Vigilância Sanitária. 
Several studies have shown that OMC present in conventional 
formulations can be systemically absorbed after skin applica-
tion, being found in the deeper layers of the stratum corneum 
as well as urine, plasma, and breast milk.8–11
The development of sunscreen formulations containing 
nanoparticulate systems is of great interest in the pharmaceu-
tical and cosmetic industries because of the many potential 
benefits, such as tailoring the release profile, improving SPF 
and stability, and reducing side effects.12–14 The crucial fac-
tor in assessing skin preparations containing nanostructures 
is the risk of permeation through transdermal, mucosal, or 
follicular pathways. Thus, it is necessary to know more 
about the cutaneous permeation, enzymatic metabolism, and 
biodistribution of these nanostructured systems in order to 
evaluate their safety.15,16
Liposomes can be defined as the result of colloidal asso-
ciation of phospholipids, which are spontaneously organized 
in closed spherical vesicles consisting of one or more phos-
pholipid bilayers that completely surround an aqueous inner 
compartment. Liposome vesicles enable the incorporation of 
both hydrophilic and lipophilic compounds.17,18
The aim of this work was to develop and evaluate a lipo-
some/OMC nanosystem and a gel formulation containing it in 
order to obtain a sunscreen formulation with improved safety 
and efficacy by keeping the OMC on the stratum corneum 
for a longer period of time.
Materials and methods
Materials
The following materials were used to prepare the formula-
tions: octyl p-methoxycinnamate, (Merck KGaA, Darmstadt, 
Germany); cholesterol, Tris(hydroxymethyl)aminomethane 
(Tris) buffer, and stannous chloride (SnCl2, Sigma-Aldrich, 
St Louis, MO, USA); phosphatidylcholine (Lipoid S 100®; 
Gerbras, Germany); high-pressure liquid chromatography-
ultraviolet grade methanol and ethanol (Tedia Brazil, 
Rio de Janeiro, Brazil); Aristoflex® AVC (ammonium 
acryloyldimethyltaurate vinylpyrrolidone copolymer) and 
alpha-tocopherol (Pharma Nostra, Rio de Janeiro, Brazil); 
methylparaben (Fagron, São Paulo, Brazil); polysorbate 80 
(Viafarma, Araraquara, Brazil); lipase from Rhizomucor 
miehei (Lipozyme®, Novo Nordisk Bioindustrial, Curitiba, 
Brazil); technetium 99 metastable (Na99mTcO4, Institute of 
Nuclear and Energy Research, São Paulo, Brazil); and sodium 
hydroxide, chloroform, hexane, and ethanol PA (Vetec 
Quimica Fina Ltda. Duque de Caxias, Brazil).
Formulation containing free OMc
In order to establish a comparison with the liposome/
OMC formulation, a gel formulation containing 8% free 
OMC was prepared. The formulation components and their 
concentrations are reported in Table 1. Methylparaben was 
solubilized in hot water, after which Aristoflex was slowly 
added to the water with vigorous mixing. The polysorbate 
80 was then added, and finally OMC was incorporated into 
the formulation.
Formulation containing liposome/OMc
The liposomal OMC preparation was obtained by a thin 
lipid film hydration method. A lipid film was formed in a 
round-bottom flask by evaporation (R-114 rotary evaporator, 
Büchi, Essen, Germany) of a mixture of 10.5 g of Lipoid S 
100, 1.55 g of cholesterol, 3.6 g of OMC, and 0.1 g of alpha-
tocopherol in 20 mL of chloroform. Next, 50 mL of Tris 
buffer (pH 6.8) was added to detach the thin film deposited 
in the flask, by mixing it in a vortex (Marconi, Piracicaba, 
São Paulo, Brazil) for 15 minutes. Sequential extrusion 
through a 0.4 µm polycarbonate membrane (Nuclepore®, 
Whatman Inc., Piscataway, NJ, USA) under nitrogen pres-
sure was carried out to homogenize the vesicle size.19 The 
nanostructured liposome/OMC system produced was char-
acterized (Figure 1). To visualize the liposomes under an 
electron transmission microscope at 80 kV (Morgagni 268, 
FEI, Hillsboro, OR, USA), samples of the liposome/OMC 
Table 1 composition of formulations containing free OMc and 
liposome/OMc
Composition Free OMC Liposome/OMC
Phase a
  Aristoflex®aVc 3% w/w 3% w/w
  Methylparaben 0.1% w/w 0.1% w/w
  Distilled water qsp 100 ml qs 100 ml
Phase B
  OMc 8% w/w 5.5% w/w
  Polysorbate 80 1% w/w –
  liposome/OMc – 50 ml =2.5 g OMc
Abbreviations: OMc, octyl methoxycinnamate; aVc, ammonium acryloyl  dimethyl-
taurate vinylpyrrolidone copolymerv; qs, quantity sufficient.International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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formulation and empty liposomes were diluted with a 25% 
ethanol solution, stained with saturated uranyl acetate solu-
tion, and dried before microscopy. Images were captured 
using a Megaview G2 digital camera (Olympus, Tokyo, 
Japan). Incorporation efficiency was the ratio between the 
mass of OMC and the mass of OMC added to the liposome 
preparation measured by a ultraviolet-visible spectropho-
tometer (V630, Jasco, Tokyo, Japan).19,20 The particle size 
distribution, polydispersity index (PI), and zeta potential were 
obtained using a particle size analyzer (Zetasizer® Nano Z, 
Malvern Instruments, Malvern, UK).
The liposome/OMC nanosystem was mixed with OMC 
and the mixture was incorporated into the gel base without 
using polysorbate 80. Two assays were performed with the 
nanostructured liposome/OMC formulation obtained, ie, 
enzymatic hydrolysis with lipase from R. miehei and biodis-
tribution of the liposome/OMC formulation labeled with 
technetium-99 m. The formulations containing   liposome/
OMC and free OMC with a final concentration of 8% 
(Table 1) were tested for ocular irritability using the hen’s 
egg test-chorio-allantoic membrane (HET-CAM) assay, in 
vitro and in vivo SPF, release profile, skin biometrics, and 
tape stripping.
enzymatic hydrolysis assay
These assays were conducted with the three substrates 
(OMC, empty liposomes, and liposome/OMC) to estab-
lish a comparison. For the lipophilic OMC (dissolved in 
hexane), a biphasic reaction medium composed of 20 mL 
of OMC in hexane solution (2 mg/mL) and 25 mL of Tris-
HCl buffer 0.05 M (pH 8.0) was used. For the liposomes, 
45 mL of the Tris-HCl buffer liposome solution (2 mg of 
liposome/mL) was used. Pretitration of the reaction mix-
tures with NaOH 0.025 N was carried out until pH 8 was 
reached. The reactions were then started by adding 5 mL of 
lipase (1:40,000 Tris buffer solution). A pH of 8.5 was kept 
constant by addition of NaOH 0.025 N using an automatic 
titrator   (Titrando 905, Herisau, Metrohm, Switzerland). 
The hydrolysis rates of the substrates were obtained and 
compared.21
Biodistribution of liposome/OMc 
formulation labeled with technetium-99m
The ethics review board and animal ethics committee of 
  Clementino Fraga Filho University Hospital   (Radiopharmacy) 
associated with the Federal University of Rio de Janeiro 
(Rio de Janeiro, Brazil) approved the study protocol.
Technetium-99m labeling was used to mark any lipo-
philic material present in the samples with Na99mTcO4 by 
  complexation. Three sample formulations were tested, ie, 
OMC, empty liposomes, and liposome/OMC. Labeling was 
carried out using 150 µL of each sample incubated with the 
same volume of SnCl2 solution (80 µL/mL) for 20 minutes 
at room temperature. These solutions were then incubated 
with 100 µCi (≈300 µL) of technetium-99 m for a further ten 
minutes to label their structures. Thin-layer chromatography 
was carried out using Whatman paper Number 1 (Maidstone, 
UK) and acetone as mobile phase to confirm correct label-
ing of the samples. The labeling procedure aimed to label 
OMC and the liposome structures (both empty liposomes and 
liposome/OMC).
Biodistribution studies were done using two Wistar rats 
for each sample. First, 1 cm2 areas of dorsal rat skin were tri-
chotomized, and after 24 hours, 0.2 mL of the labeled samples 
(3.7 MBq) was administered to the skin. Counts were acquired 
for 5 minutes in a 15% window centered at 140 KeV . The 
mice were euthanized after 30 minutes and the organs were 
removed. The organs were weighed and radioactivity uptake 
was counted in a Cobra II gamma counter (Perkin-Elmer, 
Waltham, MA, USA). The results were expressed as a percent-
age of the doses administered per gram of tissue.22
heT-caM testing for irritant  
potential of formulations
Chicken embryos have been used widely to give information 
on ocular irritant potential as an alternative to in vivo testing. 
This test is a borderline case between in vivo and in vitro 
systems and avoids problems in maintaining ethical and legal 
standards, especially with regard to animal protection laws.23 
The HET-CAM test can be used as a screening method to 
reduce the number of animals tested, to limit or eliminate pain 
and injury during animal experiments, and to allow regulatory 
authorities to establish priority and toxicity categories. It has 
Figure 1 schematic structure of the liposome containing OMc. 
Abbreviation: OMc, octyl methoxycinnamate.International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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also been expanded to include the chorio-allantoic membrane 
(CAM) test as a mucous membrane irritation test.24
Only fresh fertile eggs weighing 50–60 g can be used in 
this test. The eggs were placed in an automatically rotating 
incubator and kept at a temperature of 37.5°C ± 0.5°C and 
relative humidity of 62.5% ± 7.5%. At day 10, the embryos 
were ready to be used in the test.23
With the aid of a saw, the egg shell around the air cham-
ber was removed. The inner membrane was exposed and 
moistened using 0.9% saline solution at 37°C. Afterwards, 
it was possible to remove the inner membrane with the aid 
of tweezers, exposing the CAM. Visual analysis was done to 
verify if there were any conditions in the vascular system of 
the CAM that made the egg unsuitable for testing.23
Next 300 µL of each tested formulation was placed on the 
CAM surface. After 20 seconds, the formulation was washed 
with saline solution until completely removed. The egg was 
then observed under a magnifying glass for 5 minutes to 
determine if there were any irritant effects occurring within 
the CAM blood vessels (ie, hyperemia, hemorrhage, or 
coagulation). The procedure was repeated using four different 
eggs for each formulation.23
The irritant effects were scored (1, 3, 5, 7, or 9) accord-
ing to the time that they occurred (less than 30 seconds, 
30–60 seconds, or 60–300 seconds). The irritation level was 
considered according to the average score of the four eggs: 
0.0–0.99 corresponds to nonirritating; 1.0–4.99 corresponds 
to slightly irritating; 5.0–8.99 corresponds to moderately 
irritating; and 9.0–21 corresponds to severely irritating.23
In vitro sPF determination
In vitro SPF values were determined according to the method 
described by Mansur et al,25 which was corroborated by 
Santos et al26 using similar experimental conditions. Absorbance 
values for each formulation were determined in triplicate at a 
final OMC concentration of 2 µL/mL in ethanol and an emis-
sion spectrum of 290–320 nm with intervals of 5 nm using an 
ultraviolet-visible spectrophotometer (Jasco V630).
The SPF determination, equation (1),25 and the correla-
tion between the erythemogenic effect (EE) and the radiation 
intensity at each wavelength (EE × I) were adjusted according 
to Sayre et al:27
Spectrophotometric SPF CF EE Ia bs () = ∑
290
320
()() λλ λ
 
(1)
where the correction factor (CF) =10, EE (λ) is the erythe-
mogenic effect of radiation on wavelength λ, I(λ) is the 
intensity of solar light with wavelength λ, and abs (λ) is the 
spectrophotometric absorbance value of a solution of the 
preparation at wavelength λ.
In vivo sPF
The SPF value is defined as the ratio between the ultraviolet 
energy required to produce a minimal erythemal dose or 
redness on protected skin and the ultraviolet energy required 
to produce a minimal erythemal dose on unprotected skin 
(equation 2).
  SPF
MEDofp rotectedskin
MEDof unprotectedskin
=   (2)
The SPFs of the formulations were determined according 
to the COLIPA method.28–30
All studies were performed by Allergisa (Campinas, 
Brazil) according to Brazilian ethical protocols. Ten indi-
viduals aged 18–42 years with skin phototypes I, II or III 
were recruited as volunteers. The back of each volunteer was 
exposed to ultraviolet light using a multiport ultraviolet solar 
simulator Model 601 (Solar Light Company, Glenside, PA, 
USA). Volunteers were informed about the protocols, agreed 
to participate in the study, and gave their written consent.
On the first day, the volunteers’ backs were exposed to 
the ultraviolet simulator, and the exposure time was varied 
according to skin phototype. After about 20 hours, the 
minimal erythemal doses were observed for each volunteer. 
On the second day, the minimal erythemal doses without 
sunscreen were verified, and the tested sunscreen was then 
applied. The sunscreen samples and standard formulation 
were applied in 2 mg/cm2 amounts to an adjacent area of the 
same back of each volunteer. After application, the formula-
tion was left for 15 minutes to dry before irradiation. Each test 
area was exposed to controlled amounts of simulated sunlight 
using a solar simulator with a continuous emission spectrum 
of 290–400 nm. A 5 × 6 cm area was irradiated at six points 
(diameter 1 cm) in a series of geometrically increasing doses. 
The standard formulation was a lotion with 7% octyl dim-
ethyl para-aminobenzoic acid and 3% benzophenone-3. On 
the third day, the minimal erythemal doses of the sunscreens 
were again analyzed, and the SPF for the product was then 
calculated using the average of all the individual SPF values 
obtained for each volunteer.28,29
In vivo sPF determination  
after immersion
The SPF determined after immersion was carried out 
  according to COLIPA with ten volunteers aged 18–42 years International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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and skin phototypes I, II, or III, whose backs were exposed to 
ultraviolet light using the multiport ultraviolet solar simula-
tor Model 601.28
The in vivo SPF after immersion was determined only for 
the liposome/OMC formulation. The free OMC formulation 
was an aqueous gel, and is already known not to be water-
resistant. The objective of this test was to evaluate whether 
the liposome/OMC nanosystem was able to increase the water 
resistance of the formulation.
Water resistance was determined by evaluation of the 
volunteers after two cycles of 20-minute immersion intervals, 
with moderate activity in water at 29°C, each followed by a 
20-minute rest/air dry period until the total water exposure 
time was reached. The test areas were air-dried without 
  towels at the end of the final water immersion period.28–30
In vitro release studies
A vertical diffusion system with an artificial cellulose 
acetate membrane (27 mm diameter, 43 mm thickness, and 
0.2 µm pore size, Sigma-Aldrich) was used. This membrane 
had previously been hydrated and placed between the two 
compartments (donor and receptor). The diffusion area 
was 5.73 cm2, and the receptor compartment consisted of 
20 mL. The receptor solution consisted of 70% phosphate 
buffer (pH 7.4) containing 0.2% polysorbate 80 and 30% 
ethanol. The diffusion system was prepared, and the absence 
of bubbles between the membrane and the receptor solu-
tion was confirmed. The receptor compartment was kept 
under stirring with a magnetic bar at 900 rpm and at room 
temperature between 22°C and 25°C. After 30 minutes of 
stabilization, approximately 1 g of the formulation was 
added to the donor compartment and therefore the diffusion 
occurred under the condition of a infinite amount of active. 
Afterwards, 3.0 mL of the receptor solution was withdrawn, 
with volume replacement every 30 minutes for a total time 
of 180 minutes.19,31
Four determinations were made for each sample. 
Quantitative determination of OMC in the receptor fluid was 
done by ultraviolet spectrometry (Jasco V630). The values     
for steady-state flux diffusion were calculated for each of 
the six test units of the two formulations by linear regression 
analysis from 60 minutes onwards, considering that balance 
was achieved from this point.
In vivo skin biometrics and tape stripping
Skin biometrics and tape stripping were conducted after 
approval of the research protocol by the ethics committee 
of Clementino Fraga Filho University Hospital. Ten healthy 
female volunteers aged 22–60 years, without skin diseases 
or skin lesions, and with no history of OMC allergy were 
selected. The volunteers were informed about the protocols, 
agreed to participate in the study, and gave their written 
consent. They were not allowed to use cosmetics on their 
forearms in the 24 hours before the study.
skin biometrics
Skin biometrics is a noninvasive method used to determine 
certain characteristics of skin for evaluation of skin barrier 
integrity.32,33 The volunteers washed their forearms with 
running water and neutral soap. After drying their forearms 
with a paper towel, the volunteers stayed for one hour in a 
room with a temperature of 22°C–23°C and relative humidity 
of 60%–65%. Afterwards, the degree of hydration, pH, and 
lipid content of both forearm skin surfaces were measured 
in triplicate using a combined unit comprising a Sebumeter® 
(SM 810), pHMeter® (pH 900), and Corneometer® (820 PC), 
from Courage Khazaka (Köln, Germany).
Tape stripping
On completion of skin biometrics, five areas measuring about 
5 cm2 were delineated on the volunteers’ forearms (one as a 
control and four for testing the formulations). The formula-
tion containing free OMC was applied on the right forearm 
and the liposome/OMC formulation was applied on the left 
forearm. The formulations were administered with the aid of 
a swab in an amount of approximately 10 mg. After defined 
periods of time (15, 60, 120, and 240 minutes), the formula-
tions were removed with the aid of wet cotton. After drying 
the formulation area, 11 tape strips measuring 1 cm2 were 
sequentially applied to the skin and then quickly removed. 
The first tape was discarded, and the other ten were submitted 
to extraction with 90% ethanol. The OMC was then quanti-
fied from the extraction solution by high-performance liquid 
chromatography.34
high-performance liquid chromatography 
analysis
The concentration of OMC in the formulations and extrac-
tion solutions from tape stripping was determined by high-
performance liquid chromatography. The chromatographic 
system consisted of a Gilson model 321 pump, a Gilson 
model 152 ultraviolet-visible detector, a Gilson model 831 
temperature regulator, and a Rheodyne injector 7725i model 
(Shimadzu, Canby, OR, USA) with a 50 µL loop, a Gilson 
system interface module model 506C, and a Gilson Unipoint 
3.0 software system controller (Gilson, Bedfordshire, UK).International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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The OMC was quantified using a chromatographic 
  column (Kromasil 100 C18 reverse-phase, Sigma-Aldrich) 
5 µm, 250 × 4.6 mm, operated at 40°C, eluted with a mobile 
phase consisting of a methanol to water ratio of 9:1 at a flow 
rate of 1.5 mL per minute, and detected by ultraviolet light at 
a wavelength of 310 nm. Quantification of the compound was 
performed by measuring the peak areas in relation to those 
of chromatography standards under the same conditions.35 
The calibration curve was prepared with methanol solutions 
of OMC at concentrations ranging from 2 to 10 µg/mL. The 
standard curves were linear (r =0.999).35
statistical analysis
Experimental data are presented as the mean ± standard devi-
ation or standard error of the mean. The data were analyzed by 
paired and unpaired t-tests using Prism 6 for Windows soft-
ware (free version 6.01, GraphPad, San Diego, CA, USA). 
P,0.05 was considered to be statistically significant.
Results
liposome characterization
The liposomes showed multilayered and spherical vesicles 
with homogeneous morphology (Figure 2). The mean 
Table  2  Diameter,  polydispersity  index,  and  zeta  potential  of 
liposomes
Sample Diameter  
(nm)
PI Zeta potential   
(mV)
empty liposome 483.20 ± 27.70 0.272 ± 0.033 -11.27 ± 0.46
liposome/OMc 982.00 ± 68.00 0.464 ± 0.050 -10.31 ± 0.58
Note: Values are shown as the mean ± standard deviation. 
Abbreviations: OMc, octyl methoxycinnamate; PI, polydispersity index.
Figure  2  electron  transmission  photomicrographs  of  empty  liposome  (A)  and 
liposome/octyl methoxycinnamate (B).
diameters of the liposome/OMC and empty liposome for-
mulations (n=3) were, respectively, 982.00 ± 68.00 with 
a PI of 0.464 ± 0.050 and 483.20 ± 27.70 nm with a PI 
of 0.272 ± 0.033 (Table 2). The liposomes were stored 
in a refrigerator with a temperature range of 4°C–8°C. 
After 3 months, the mean empty liposome diameter was 
621.93 ± 48.43 nm with a PI of 0.127 ± 0.021 and the mean 
liposome/OMC diameter was 1066 ± 32.66 nm with a PI 
of 0.545 ± 0.029. These data indicate a small increment in 
vesicle diameter over time. The PI indicates sample quality. 
PI values near 0.1 are associated with a monodispersed 
system, with a highly homogeneous population of particles, 
suggesting a monomodal size distribution. On the other hand, 
high PI values (near to 1.0) suggest a polymodal or a wide 
size distribution of particles.36 The results showed a PI ,0.5, 
indicating that the vesicle population was homogeneous and 
monomodal. The liposome incorporation efficiency for OMC 
was 84.97 ± 2.02 (n=3). The zeta potentials of the liposome/
OMC and empty liposome formulations (Table 2) were the 
same statistically (P,0.05), with values of –10.31 ± 0.58 
and –11.27 ± 0.46, respectively.
enzymatic hydrolysis assay
The aim of this test was to compare the hydrolysis rate 
of the OMC sunscreen agent with that of the liposome/
OMC formulation to determine the skin metabolism of 
the two   formulations. The hydrolysis rate of the OMC 
sunscreen under the experimental conditions used was 
4.439 ± 0.028 µmol per minute. The other substrates tested, 
ie, the liposome/OMC and empty liposome formulations, 
were not hydrolyzed by lipase since the volume consump-
tion of the blank samples was almost the same as that of the 
samples containing empty liposomes and liposome/OMC 
(0.096 mL and 0.19 mL, respectively).
Biodistribution of liposome/OMc  
labeled with technetium-99m
All the samples were successfully labeled (.90%). The use 
of acetone as mobile phase provided efficient separation International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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from free technetium-99 m and the labeled formulations. 
These tests were performed with the empty liposomes, 
  liposome/OMC, and free OMC to assess whether the 
  liposome/OMC formulation is capable of forming a reser-
voir and being retained in the skin, since it is known that 
the OMC incorporated in conventional sunscreen formula-
tions is able to cross the skin barrier and reach the systemic 
circulation.8–12,37 The results show that the empty liposomes 
and liposome/OMC formulation had similar biodistribution 
profiles. As shown in Figure 3, the main organ of OMC 
deposition was the liver, indicating that OMC is rapidly 
absorbed after application to the skin and undergoes hepatic 
metabolism. The second organ of deposition was the skin, 
while the amounts found in other tissues evaluated were 
not significant for OMC. Analyzing the bar graphs for the 
liposomes, it can be seen that the main organ of deposi-
tion for this nanosystem was the skin, suggesting that the 
empty liposomes and the liposome/OMC formulation have 
a higher affinity for this organ compared with free OMC, 
so remain on the skin for longer. The liposome samples 
showed some small deposition in the liver, which could 
be due to phospholipids or trapped OMC, but in lower 
amounts when compared with the OMC sample, suggesting 
that there was little systemic absorption of the liposomes 
or their components through the skin.
heT-caM test for irritant potential  
of the formulations
The gel and liposome/OMC formulations had irritation scores 
of 0.45 and 0.25, respectively (Table 3), while the empty lipo-
some and free OMC gel formulations had scores of zero. All 
test formulations had a final classification of “nonirritating” 
according to the HET-CAM test.
In vitro sPF determination
The liposome/OMC and free OMC formulations had SPF 
values of 13.88 ± 0.07 and 13.98 ± 0.66, respectively. 
These in vitro SPF values were not significantly different 
between the formulations (unpaired t-test, P,0.05), as seen 
in Figure 3.
In vivo sPF before and after immersion
SPF determination in vivo showed a value of 7.0 ± 1.6 
for the formulation containing free OMC, and a value of 
11.5 ± 2.7 for the liposome/OMC formulation   (Figure 4). 
Statistical analysis showed that the in vivo SPF values for 
the formulations were significantly different.   Therefore, 
it can be concluded that the liposome/OMC was able to 
increase the SPF of the formulation. The SPF after immer-
sion of the liposome/OMC formulation was 5.8 ± 1.4 
(Figure 4). This value was significantly   different from 
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Table 3   Score  and  classification  of  irritation  obtained  in  the 
heT-caM test
Formulations Irritation scores Degree of irritation
gel base 0.45 Nonirritant
Free OMc gel 0 Nonirritant
empty liposome 0 Nonirritant
liposome/OMc 0.25 Nonirritant
Abbreviations: heT-caM, hen’s egg test-chorio-allantoic membrane; OMc, octyl 
methoxycinnamate.
the SPF before   immersion. Therefore, it can be con-
cluded that the liposome/OMC formulation has low water 
resistance.
In vitro release studies
The free OMC gel formulation showed a higher steady-
state flux diffusion value of 6.3 ± 1.21 µg/cm2/hour, 
releasing higher amounts of filter to the receptor solution 
(24.06 ± 3.62 µg/cm2) at the end of 180 minutes (Figure 5). 
The higher standard error values     indicate that there was 
greater variability between the six cells used.
The liposome/OMC gel formulation had a steady-state 
flux diffusion value of 3.9 ± 0.33 µg/cm2/hour and released 
14.70 ± 0.98 µg/cm2 of OMC after 180 minutes (Figure 5). 
This formulation showed a low standard deviation, indicating 
small variability between the six cells used. Statistical analy-
sis showed that there was a significant difference between 
the steady-state flux diffusion values of the   liposome/OMC 
and conventional gel formulations. The amounts of sun-
screen released per area were significantly different from 
the 90-minute point (Figure 4), indicating that the two for-
mulations release OMC in a different manner and that the 
liposome is able to modify OMC release.
In vivo skin biometrics
The lipid content of the forearms was zero in all cases. The 
degree of hydration of the skin was below 80 AU in all 
volunteers.32,33 For this reason, all were classified as having 
dry skin.
The pH of the skin showed a large variation between 
volunteers, with the majority having higher pH values than 
the range reported in the literature, ie, 5.5–5.8.32,33 To inves-
tigate the results further, the volunteers were divided into 
two groups, ie, those with cutaneous pH #7.4 and those with 
cutaneous pH .7.4 (Figure 6). Applying the same reason-
ing to the degree of hydration, the volunteers were divided 
into those with skin hydration #35 AU and those with skin 
hydration .35 AU (Figure 7). These data were analyzed 
together with the amounts of OMC per area found in the 
stratum corneum in order to determine if different ranges of 
pH or degree of hydration influenced OMC uptake by the 
stratum corneum. Statistical analysis of the graphs for the 
free OMC formulation showed that there were no statisti-
cally significant differences between the amounts of OMC 
retained in the stratum corneum in skin with pH #7.4 and 
skin with pH .7.4. The same occurred with the hydration 
graphs, in that there were no statistically significant differ-
ences between the groups with hydration degrees #35 AU 
and .35 AU. The differences in pH and degree of hydration 
in volunteer skin did not significantly alter OMC uptake by 
the stratum corneum.International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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Tape stripping
Based on the results shown in Figure 8, it can be seen that 
after 240 minutes the amount of OMC recovered per area 
in the total number of strips was 22.64 ± 7.55 µg/cm2 in the 
stratum corneum of forearms treated with the liposome/
OMC formulation and 14.57 ± 2.30 µg/cm2 in those treated 
with the free OMC formulation. The formulations were sig-
nificantly different at 60, 120, and 240 minutes (Figure 8). 
OMC uptake by the stratum corneum was higher after 
treatment with the liposome/OMC formulation compared 
with conventional free OMC. Figure 9 shows the percent-
age amount of OMC recovered in the total number of strips 
removed after different durations of application. The results 
are the mean values for the ten volunteers at each time point. 
After 4 hours, the percentage of the initial dose recovered 
from the ten tape strips did not exceed 2%. However, the 
liposomes showed a higher percentage recovery than the 
conventional formulation.
Discussion
characterization of liposome/OMc 
formulation
Liposome/OMC vesicles were successfully prepared by the 
thin film hydration method. After preparation, physicochemi-
cal characterization showed that the liposome/OMC formula-
tion had a greater mean diameter and PI compared with the 
empty liposomes. This probably happened because OMC 
makes the liposome more unstable, causing coalescence of 
vesicles, thus increasing the mean diameter and PI of the 
liposome/OMC formulation. The OMC sunscreen agent International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
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  demonstrated high encapsulation efficiency when incor-
porated into the phosphatidylcholine liposome, which was 
expected since OMC is a lipophilic compound and remains 
mixed in the phospholipid bilayer formed.38
Although there were no charged components in the lipo-
some vesicle, the liposomes had negative zeta potential values. 
This is due to the phosphate group present in the polar head 
of phosphatidylcholine, which is directed towards the outside 
of the vesicle. This direction is probably due to the low ionic 
strength of the liposomal suspension. The fact that liposomes 
are negatively charged is important, because the repulsion 
of charges increases stability and prevents coalescence of 
vesicles. However, this low negative charge is not enough 
to keep them stable for long.12,39,40
enzymatic hydrolysis assay
The liposome/OMC formulation was not hydrolyzed by 
lipase in the enzymatic hydrolysis assay. This was probably 
due to the arrangement of phosphatidylcholine in the lipo-
some bilayer. The phosphatidylcholine fatty acid moieties 
are turned towards the inner side of the vesicles, preventing 
enzymatic hydrolysis of the ester groups. Therefore, it can 
be concluded that the liposome is capable of protecting the 
filter against the lipase enzymatic degradation caused by 
lipases present in the stratum corneum, thereby increasing 
the residence time of the vesicle on the skin.39,34
Biodistribution of liposome/OMc labeled 
with technetium-m99
The technetium-labeled liposomes showed higher affinity 
for the skin than the ultraviolet-filtered OMC, confirming 
that OMC can be systemically absorbed after application 
to the skin, and demonstrating the potential of liposomes International Journal of Nanomedicine 2013:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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to form a reservoir on the skin while minimizing systemic 
absorption of OMC.
In vitro and in vivo sPF
The in vitro SPF values for the formulations tested were not 
significantly different. This may be because of the limitations 
of the spectrophotometric method in assessing the interac-
tions of the formulations with the skin. This result is based 
on the total concentration of the ultraviolet filter in the for-
mulations. The in vitro SPF test is rapid and cost-effective, 
and can estimate the SPF of formulations prior to in vivo 
SPF tests in humans.25,26
Inclusion of OMC in liposomes increased the in vivo 
SPF values for the formulation. However, the SPF decreased 
after immersion, indicating that the liposome/OMC formu-
lation had low water resistance. This is probably because 
the   liposome/OMC is embedded in a totally aqueous gel 
formulation. The liposome itself did not provide the formula-
tion with water resistance.
heT-caM test
As expected, the liposome formulation was deemed nonir-
ritating to the mucous membranes, since the components 
of the liposome vesicles are substances present in skin 
phospholipids and cholesterol. The vehicle gel and free 
OMC formulations were also considered nonirritating to 
the mucous membranes. This test is important given that 
photoprotective formulations can be applied to the face, so 
may reach the eyes and mouth.
In vitro release studies
The release profile for the liposome/OMC formulation was 
significantly different from that of the conventional free 
OMC formulation. The amounts of sunscreen transferred 
per area were different from the 90-minute point onwards, 
showing that the liposome is able to modify OMC release 
from the gel formulation. The liposome probably alters 
the thermodynamic activity of the formulation, ie, slowing 
down diffusion of OMC to the receptor fluid. The liposome 
provides a lipophilic environment for OMC, which hinders 
diffusion to the receptor solution. This does not occur with 
the formulation containing free OMC because it is totally 
hydrophilic.37,41
skin biometrics and tape stripping
Skin biometrics showed that the differences in pH and hydra-
tion of the volunteers’ forearm surfaces did not significantly 
influence (P,0.05) uptake of OMC by the stratum corneum. 
This result is important because pH and hydration of the 
stratum corneum can modify skin barrier properties, giving 
different OMC uptake results.42
Penetration of these two formulations containing OMC 
(liposome and conventional) into the skin was investigated by 
tape stripping, a technique that allows removal of the stratum 
corneum and quantification of drugs and cosmetic active 
ingredients on the skin surface.42,43 The results demonstrated 
that higher amounts of OMC per area were recovered from the 
strips for the liposome/OMC formulations (Figure 8) and the 
percentage of OMC in relation to the dose applied was higher 
for the liposome/OMC formulation in comparison with the 
conventional free OMC formulation. The liposome/OMC 
formulation may mix with intercellular lipids and cause them 
to swell without altering the multiple bilayer structure of the 
stratum corneum, producing an extra lipid barrier in the skin, 
given that intercellular lipids are important in controlling 
percutaneous absorption.44 Our results are similar to those 
reported by Monteiro et al,19 whose work demonstrated that 
larger amounts of OMC were found on pig ear epidermis 
following application of a liposomal formulation containing 
OMC. In their work, approximately 56% of the liposomal 
OMC applied remained in the epidermis and only 29% passed 
to the dermis. Thus, the liposome can provide a modified-
release carrier system and act as a reservoir for OMC, causing 
OMC to remain for longer in the upper layers of the stratum 
corneum, increasing SPF, diminishing enzymatic degradation 
of OMC by epidermal metabolism, and avoiding systemic 
absorption. These results strongly indicate that liposomes are 
superior carriers for OMC as a sunscreen due to their higher 
retention in the stratum corneum, their ability to minimize 
penetration into the deeper skin layers, and their ability to 
provide a higher in vivo SPF value.
Conclusion
Liposomes prepared by the thin film hydration method 
could be a better carrier for OMC, an anti-ultraviolet B 
filter, compared with conventional free OMC formulations, 
because it has a higher SPF, no irritation potential, an abil-
ity to resist lipase enzymatic degradation, and a capacity to 
modify OMC release and form a reservoir, thus remaining 
in greater amounts in the stratum corneum and minimizing 
systemic absorption of OMC. The liposome/OMC formula-
tion is therefore a better vehicle for OMC than conventional 
formulations.
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